7-148229703-T-C

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_014141.6(CNTNAP2):​c.3305T>C​(p.Val1102Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000401 in 1,614,116 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V1102I) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0022 ( 1 hom., cov: 32)
Exomes 𝑓: 0.00022 ( 4 hom. )

Consequence

CNTNAP2
NM_014141.6 missense

Scores

17

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 2.88

Publications

5 publications found
Variant links:
Genes affected
CNTNAP2 (HGNC:13830): (contactin associated protein 2) This gene encodes a member of the neurexin family which functions in the vertebrate nervous system as cell adhesion molecules and receptors. This protein, like other neurexin proteins, contains epidermal growth factor repeats and laminin G domains. In addition, it includes an F5/8 type C domain, discoidin/neuropilin- and fibrinogen-like domains, thrombospondin N-terminal-like domains and a putative PDZ binding site. This protein is localized at the juxtaparanodes of myelinated axons, and mediates interactions between neurons and glia during nervous system development and is also involved in localization of potassium channels within differentiating axons. This gene encompasses almost 1.5% of chromosome 7 and is one of the largest genes in the human genome. It is directly bound and regulated by forkhead box protein P2, a transcription factor related to speech and language development. This gene has been implicated in multiple neurodevelopmental disorders, including Gilles de la Tourette syndrome, schizophrenia, epilepsy, autism, ADHD and intellectual disability. [provided by RefSeq, Jul 2017]
CNTNAP2 Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AR, AD Classification: DEFINITIVE, NO_KNOWN Submitted by: ClinGen
  • cortical dysplasia-focal epilepsy syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Illumina, Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.010503858).
BP6
Variant 7-148229703-T-C is Benign according to our data. Variant chr7-148229703-T-C is described in ClinVar as Likely_benign. ClinVar VariationId is 205221.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Homozygotes in GnomAdExome4 at 4 AR,AD gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_014141.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CNTNAP2
NM_014141.6
MANE Select
c.3305T>Cp.Val1102Ala
missense
Exon 20 of 24NP_054860.1A0A090N7T7

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CNTNAP2
ENST00000361727.8
TSL:1 MANE Select
c.3305T>Cp.Val1102Ala
missense
Exon 20 of 24ENSP00000354778.3Q9UHC6-1
CNTNAP2
ENST00000628930.2
TSL:2
c.482T>Cp.Val161Ala
missense
Exon 5 of 9ENSP00000487516.1B7Z1Y6
CNTNAP2
ENST00000627772.2
TSL:2
n.1478T>C
non_coding_transcript_exon
Exon 9 of 13

Frequencies

GnomAD3 genomes
AF:
0.00219
AC:
333
AN:
152126
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00772
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000655
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.000479
GnomAD2 exomes
AF:
0.000573
AC:
144
AN:
251366
AF XY:
0.000515
show subpopulations
Gnomad AFR exome
AF:
0.00818
Gnomad AMR exome
AF:
0.000202
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000352
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000215
AC:
315
AN:
1461872
Hom.:
4
Cov.:
33
AF XY:
0.000197
AC XY:
143
AN XY:
727234
show subpopulations
African (AFR)
AF:
0.00812
AC:
272
AN:
33480
American (AMR)
AF:
0.000224
AC:
10
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39696
South Asian (SAS)
AF:
0.0000116
AC:
1
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53414
Middle Eastern (MID)
AF:
0.000173
AC:
1
AN:
5768
European-Non Finnish (NFE)
AF:
0.00000540
AC:
6
AN:
1112000
Other (OTH)
AF:
0.000397
AC:
24
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.467
Heterozygous variant carriers
0
18
37
55
74
92
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00219
AC:
333
AN:
152244
Hom.:
1
Cov.:
32
AF XY:
0.00204
AC XY:
152
AN XY:
74438
show subpopulations
African (AFR)
AF:
0.00770
AC:
320
AN:
41546
American (AMR)
AF:
0.000654
AC:
10
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4824
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10600
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000294
AC:
2
AN:
68014
Other (OTH)
AF:
0.000474
AC:
1
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
16
33
49
66
82
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000862
Hom.:
0
Bravo
AF:
0.00220
ESP6500AA
AF:
0.00726
AC:
32
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000651
AC:
79
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.0000545
EpiControl
AF:
0.000119

ClinVar

ClinVar submissions
Significance:Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
not specified (3)
-
-
2
not provided (2)
-
-
1
Cortical dysplasia-focal epilepsy syndrome (1)
-
-
1
Inborn genetic diseases (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.23
BayesDel_addAF
Benign
-0.49
T
BayesDel_noAF
Benign
-0.47
CADD
Benign
14
DANN
Benign
0.78
DEOGEN2
Benign
0.17
T
Eigen
Benign
-0.82
Eigen_PC
Benign
-0.88
FATHMM_MKL
Benign
0.21
N
LIST_S2
Benign
0.67
T
MetaRNN
Benign
0.011
T
MetaSVM
Benign
-0.83
T
MutationAssessor
Benign
1.7
L
PhyloP100
2.9
PrimateAI
Benign
0.41
T
PROVEAN
Benign
-1.1
N
REVEL
Benign
0.22
Sift
Benign
0.38
T
Sift4G
Benign
0.39
T
Polyphen
0.54
P
Vest4
0.40
MVP
0.81
MPC
0.13
ClinPred
0.012
T
GERP RS
0.45
Varity_R
0.039
gMVP
0.33
Mutation Taster
=96/4
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs111599875; hg19: chr7-147926795; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.